Samsung Introduces R20 Ultrasound System with Improved Imaging and Clinician Comfort

New R20 System Delivers Clearer Scans, Greater Accuracy, and Ergonomic Design to Improve Efficiency and Patient Care.

The Samsung R20 Ultrasound System will be launched by Samsung Medison, a multinational medical equipment company and part of Samsung Electronics, at the Radiological Society of North America (RSNA) 2025 Annual Meeting in Chicago, Illinois. With its improved diagnosis precision and AI-driven technologies powered by modern hardware and new image formation technologies, the R20 brings in a new era of ultrasound innovation. It also introduces ergonomic innovations that have been independently validated to improve user comfort and scanning efficiency.

Rising obesity and chronic disease are making ultrasound tests more complex leading to higher percentages of unclear outcomes and creating a need for improved imaging technologies that enable deeper penetration intelligent clinical support and diagnostic consistency. At the same time, the importance of ergonomic design is highlighted by the prevalence of sonographer pain and labor shortages. The R20 was developed to face these difficulties head-on, merging imaging precision, AI and ergonomics in a single solution.

Samsung's Advanced Imaging Engine, which combines modern technology with complex software beam shaping to create extraordinary image quality and diagnostic accuracy, powers the R20, which is designed for exceptional imaging performance. R20 includes more than a dozen AI-powered tools for current exam guidance, diagnostic support, workflow automation and automated measurements to help healthcare providers increase accuracy, save time and scan with greater confidence in challenging cases. Complementing its clinical efficacy, the R20 received independent validation as a leader in ergonomic innovation, satisfying 100% of established ergonomic standards and recommendations to increase clinician comfort and healthy scanning.

According to Tracy Bury, Chief Commercial Officer of Samsung Healthcare in the USA and Vice President of Global Growth Initiatives, the R20 reflects their ambition to improve diagnostic imaging through intentional innovation. Additionally, the R20's technologies are developed as useful tools that significantly improve the way clinicians operate and patients are cared for, due to close collaboration with clinicians. With the R20, they're transforming ultrasound from a fast follower to a true technology leader by speeding innovation.